Prospects for prophylactic hepatitis C vaccines based on virus-like particles
Open Access
- 14 May 2013
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 9 (5) , 1112-1118
Abstract
Given the global prevalence and long-term complications of chronic hepatitis C virus (HCV) infection, HCV constitutes one of the greatest challenges to human health of this decade. Considerable efforts have focused on the development of new effective treatments, but about three to four million individuals become infected each year, adding to the world reservoir of HCV infection. The development of a prophylactic vaccine against hepatitis C virus has thus become an important medical priority. Only a few vaccine candidates have progressed to the clinical phase, and published data on both the efficacy and safety of these vaccines are limited, due to many scientific, logistic and bioethic challenges. Fortunately, new innovative vaccine formulations, modes of vaccination and delivery technologies have been developed in recent years. Several preclinical trials of virus-like particle (VLP)-based vaccination strategies are currently underway and have already generated very promising results. In this commentary, we consider the current state of prophylactic HCV vaccines, the hurdles to be overcome in the future and the various VLP-based vaccination approaches currently being developed.Keywords
This publication has 75 references indexed in Scilit:
- Progress in the development of preventive and therapeutic vaccines for hepatitis C virusJournal of Hepatology, 2011
- Meta-Analysis of Hepatitis C Virus Vaccine Efficacy in Chimpanzees Indicates an Importance for Structural ProteinsGastroenterology, 2010
- Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adultsVaccine, 2010
- Selection-Driven Immune Escape Is Not A Significant Factor in the Failure of Cd4 T Cell Responses in Persistent Hepatitis C Virus InfectionHepatology, 2010
- Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent ReinfectionGastroenterology, 2010
- Selection Pressure From Neutralizing Antibodies Drives Sequence Evolution During Acute Infection With Hepatitis C VirusGastroenterology, 2009
- Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particlesVirology, 2008
- Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis CProceedings of the National Academy of Sciences, 2007
- CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virusHepatology, 2006
- Production of infectious hepatitis C virus in tissue culture from a cloned viral genomeNature Medicine, 2005